Comparative Pharmacology
Head-to-head clinical analysis: DEFERIPRONE versus JADENU SPRINKLE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEFERIPRONE versus JADENU SPRINKLE.
DEFERIPRONE vs JADENU SPRINKLE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Deferiprone is an iron chelator that binds to ferric iron (Fe3+) to form a stable complex, promoting iron excretion in urine. It reduces iron overload in tissues and prevents iron-induced free radical damage.
Deferasirox is an oral iron chelator that selectively binds iron (Fe3+) with high affinity, forming a stable complex that is excreted primarily in the feces. It reduces iron overload by promoting iron excretion.
75 mg/kg/day orally in three divided doses (maximum 3 g/day).
Oral: Initial 20 mg/kg/day (max 30 mg/kg/day) administered once daily; titrate based on serum ferritin. For patients >14 years with serum ferritin >1000 mcg/L, use 20 mg/kg/day. Sprinkle capsules can be opened and contents sprinkled on soft food.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Deferiprone
"The serum concentration of Deferiprone can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium salicylate + Deferiprone
"The serum concentration of Deferiprone can be decreased when it is combined with Magnesium salicylate."
Clinical Note
moderateIron sucrose + Deferiprone
"The serum concentration of Deferiprone can be decreased when it is combined with Iron sucrose."
Clinical Note
moderateIron + Deferiprone
2-3 hours (terminal elimination half-life). Due to its short half-life, multiple daily doses are required to maintain therapeutic chelation; levels decline rapidly after dose cessation.
8–28 hours (mean 11–19 hours); prolonged half-life correlates with iron overload and may require dose adjustments.
Primarily renal excretion as iron complex (ferrioxamine) and unchanged drug; 70-90% of a dose is recovered in urine within 24 hours, predominantly as the iron chelate. Less than 10% is eliminated in feces via biliary excretion.
Primarily fecal (84% of absorbed dose); renal excretion accounts for approximately 8% of total clearance.
Category C
Category C
Iron Chelator
Iron Chelator
"The serum concentration of Deferiprone can be decreased when it is combined with Iron."